We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lab-on-Chip Identifies and Differentiates Tropical Pathogens

By LabMedica International staff writers
Posted on 13 Aug 2014
Tropical pathogens often cause febrile illnesses in humans and are responsible for considerable morbidity and mortality and the similarities in clinical symptoms provoked by these pathogens make diagnosis difficult.

A microfluidic lab-on-chip integrating multiplex molecular amplification and DNA microarray hybridization has been developed for simultaneous detection and species differentiation of 26 globally important tropical pathogens.

A multinational team of scientists working with the Agency for Science, Technology and Research (A*STAR; Biopolis, Singapore) collected plasma samples from 30 polymerase chain reaction (PCR)-confirmed Chikungunya virus (CHIKV) patients, 125 archived nuclei acid samples extracted from specimens from a malaria clinic, and non-malaria specimens collected from patients presenting with undifferentiated febrile illness were also evaluated with the lab-on-chip. More...


The microfluidic technology was combined with reverse transcription (RT), PCR amplification, and microarray hybridization to develop silicon based micro-electromechanical systems (MEMS) integrated lab-on-chip that can simultaneously detect and differentiate between 26 pathogen species, including bacteria, parasites and viruses, that cause 14 tropical diseases. The lab-on-chip was scanned in an optical reader (Veredus Laboratories; Singapore) which has an excitation filter for Cyanine 5 (Cy5).

The analytical performance of the lab-on-chip for each pathogen ranged from 102 to 103 DNA or RNA copies. Assay performance was further verified with human whole blood spiked with Plasmodium falciparum and Chikungunya virus that yielded a range of detection from 200 to 4×105 parasites and from 250 to 4×107 plaque-forming units (PFU) respectively. This lab-on-chip was subsequently assessed and evaluated using 170 retrospective patient specimens in Singapore and Thailand.

The lab-on-chip had a detection sensitivity of 83.1% and a specificity of 100% for P. falciparum; a sensitivity of 91.3% and a specificity of 99.3% for P. vivax; a positive 90.0% agreement and a specificity of 100% for Chikungunya virus; and a positive 85.0% agreement and a specificity of 100% for Dengue virus serotype 3 with reference methods conducted on the samples.

The authors concluded that the lab-on-chip assay showed that miniaturized multiplex PCR could reach the desired clinical sensitivity; future work should attempt to recalibrate the mix of multiplex primers and modify amplification cycling conditions for improved sensitivity. One of the key milestones for lab-on-chip systems would be the direct testing of clinical specimens obtained during the acute infection phase and provide accurate diagnosis to complement clinical assessments. The study was published on July 31, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Agency for Science, Technology and Research
Veredus Laboratories




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers found that tumor DNA fragments in blood can reveal ongoing prostate cancer growth even when current tests show little change (image credit: Adobe Stock)

Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer

Prostate cancer is the most common cancer in the U.K., with more than 64,000 men diagnosed and 12,000 deaths each year. For the roughly 10,000 men annually with advanced disease, early assessment of treatment... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.